EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The clinical impact of androgens in endometrial cancer: cancer promoter or suppressor?

Xirong Wu iD, Wenyan Tian iD, Yingmei Wang iD

Endocrine Oncology · 01.01.2026 · 6 (1)

DOI: 10.1530/eo-25-0040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Oncology, online erschienen am 11.03.2026. Verfasst von Xirong Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Androgens are associated with the risk of endometrial carcinoma (EC). However, their roles as prognostic factors are less clear. This study aims to investigate the prognostic impact of different androgens.

Methods

We conducted a retrospective cohort study of patients who had previous endometrial sampling that showed EC between August 19, 2003, and November 4, 2015. This study included 465 patients with an average follow-up of 37 months. We examined associations between endogenous testosterone levels (total, bioavailable and free testosterone) and the clinical outcomes in patients with EC. Serum levels of bioavailable testosterone were calculated using the total testosterone level and the sex hormone-binding globulin concentration (measured by chemiluminescent and radioimmunoassays, respectively).

Results

Higher circulating concentrations of total and bioavailable testosterone were associated with a higher risk of type I endometrial cancer (OR = 1.015, 95% CI: 1.008–1.022; OR = 1.395, 95% CI: 1.266–1.536, respectively), but the similar association was not found in type II patients (OR = 1.009, 95% CI: 0.998–1.020; OR = 1.208, 95% CI: 0.998–1.461, respectively). However, higher levels of testosterone in EC patients correlated with favorable clinicopathological features, especially bioavailable and free testosterone. Furthermore, Kaplan–Meier survival analysis indicated that elevated bioavailable and free testosterone levels were associated a longer overall survival (P = 0.048, P = 0.036, respectively), but this trend was not statistically significant after adjustment for other prognostic factors (P = 0.312, P = 0.272, respectively).

Conclusion

Elevated serum testosterone levels were associated with an increased risk of type I cancers. Although androgens showed certain prognostic values, they were not independent prognostic factors. Different androgenic indexes showed different clinical implications. The risk estimates could refer to total and/or bioavailable testosterone. Bioavailable and/or free indexes may be better markers for the probable prognostic effects.

Schlagwörter

Stichwörter der Autor:innen

androgenendometrial carcinomaprognosisrisk–benefit

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.
  • Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, China.
  • Department of Gynecology and Obstetrics, Affiliated Hospital of Nantong University, Nantong, China.

ORCID-Profile: Xirong Wu, Wenyan Tian, Yingmei Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, X., Tian, W., & Wang, Y. (2026). The clinical impact of androgens in endometrial cancer: cancer promoter or suppressor?. Endocrine Oncology, 6(1). https://doi.org/10.1530/eo-25-0040

Vancouver

Wu X, Tian W, Wang Y. The clinical impact of androgens in endometrial cancer: cancer promoter or suppressor?. Endocrine Oncology. 2026;6(1). doi:10.1530/eo-25-0040

BibTeX
@article{Wu2026,
  author = {Wu, Xirong and Tian, Wenyan and Wang, Yingmei},
  title = {The clinical impact of androgens in endometrial cancer: cancer promoter or suppressor?},
  journal = {Endocrine Oncology},
  year = {2026},
  volume = {6},
  number = {1},
  doi = {10.1530/eo-25-0040}
}
Kostenlos starten →